Copper Cu 64 Anti-CEA Monoclonal Antibody M5A PET in Diagnosing Patients With CEA Positive Cancer

Clinical trial NCT02293954 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT02293954
Sponsor: City of Hope Medical Center
Status: ACTIVE_NOT_RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

Breast Cancer Colon Cancer Extrahepatic Bile Duct Cancer Gallbladder Cancer Gastrointestinal Cancer Liver and Intrahepatic Biliary Tract Cancer Lung Cancer Metastatic Cancer Pancreatic Cancer Rectal Cancer Thyroid Gland Medullary Carcinoma Unspecified Adult Solid Tumor, Protocol Specific

Start date: 2015-11-11
Primary completion: 2022-03-06
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.